ABSTRACT In a retrospective study of 377 patients with bronchial carcinoma, sputum had been reported positive or suspicious for malignant cells in 59 7%. The 
There was no significant difference in the radiological appearances of the tumours in each group of patients (table 3) . Positive cytology was obtained in 55% of the tumours of less than 5 cm in diameter, in 62% of greater than 5 cm in diameter, and in 63% of the tumours associated with collapse and consolidation. This agrees with previous reports that larger tumours and those One hundred and fifty-three patients in the positive group were examined bronchoscopically and 127 (83%) of these had a visible abnormality and were, therefore, classified as having central tumours. The remaining 26 (17%) had no visible abnormality and the tumours were regarded as peripheral in site. In the negative group 112 patients had bronchoscopy, 80 (71-4%) had central, and 32 (28-6%) peripheral tumours. In the true negative group 22 patients (50%) had a central lesion and 22 a peripheral lesion. This difference in tumour site betwen the positive group and true negative group was highly significant (p<0*00l1). Central tumours yield a higher proportion of positive results;4 thus the relatively smaller proportion of patients with central tumours in the negative and especially the true negative groups makes positive cytology less likely.
Sputum samples were purulent in 37.3% of the patients in the positive group, 36-8% in the negative group, and 35-2% in the true negative group. There was no significant difference between the groups.
In the positive group 46-7% of the patients were considered to be in poor There were significantly more patients in the epidermoid group with positive cytology (p < 0 05).
There were significantly more patients in the central group with positive cytology (p < 0-01).
In 40-3% of our patients the diagnosis was not confirmed by sputum cytology. Many factors may contribute to this: (1) inadequate number and unsatisfactory sputum specimens; (2) sputum infected and frankly purulent; (3) patient unable to produce sputum; (4) size and position of the tumour; (5) histology of the tumour; (6) tumour does not exfoliate; (7) degeneration of malignant cells in the sputum before examination.
In this series a significant number of patients in the negative group (28.3%) produced no satisfactory specimens. For consistent and reliable results special care must be taken to ensure adequate and satisfactory sputum samples. The staff collecting the samples should be experienced in the correct technique and should give explicit instructions to the patient. Written instructions have been shown to be of benefit.4 There is good evidence that the greater the number of satisfactory samples examined the greater the likelihood of confirming the diagnosis.1 2 6 As an experienced cytologist requires 10-20 minutes to examine each slide,7 for practical purposes it is generally accepted that three or four satisfactory samples are optimal.
The presence of pus in the specimens makes cytological examination unsatisfactory and contributes to a negative result.6 This was not an important factor as in the majority of patients the sputum was mucoid and purulence was present in a similar proportion of the positive and negative groups. A large number of patients submit secretions from the upper respiratory tract or saliva. All samples should, therefore, be screened for the presence of alveolar histiocytes before proceeding with the examination for malignant cells.
Many 
